Loading provider…
Loading provider…
Neurology Physician in Chicago, IL
NPI: 1235346941Primary Practice Location
RUSH UNIVERSITY MEDICAL CENTER
1620 W Harrison St, Chicago, IL
Primary Employer
Rush University Internists
rush.edu
HQ Phone
Get MD Sean's Phone Numberphone_androidMobile
Get MD Sean's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
The University of Texas Health Science Center at San Antonio
Medical School
Until 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 54 | 94 |
| 2 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 20 | 27 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden
Authors: Daniel I. Jacobs, Priya Kumthekar, Becky V. Stell, Sean Grimm, Alfred Rademaker, Laurie Rice, James P. Chandler, Kenji Muro, Mary Anne H Marymont, Irene Helenowski, Lynne I. Wagner, Jeffrey Raizer
Publication Date: 2014-06
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, PROCEDURE: Conventional Surgery, RADIATION: Fractionated Stereotactic Radiation Therapy, BIOLOGICAL: Atezolizumab, BIOLOGICAL: Tocilizumab
Lead Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Targeted Molecular Therapy